Name: Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: HIT3542
Price: 4950 USD
Availability: InStock

1 INTRODUCTION 43 1.1 STUDY OBJECTIVES 43 1.2 MARKET DEFINITION 43 1.2.1 TELEHEALTH 43 1.2.2 TELEMEDICINE 43 1.3 STUDY SCOPE 44 1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD 44 1.3.2 INCLUSIONS & EXCLUSIONS 45 1.3.3 YEARS CONSIDERED 47 1.3.4 CURRENCY CONSIDERED 47 1.4 STAKEHOLDERS 47 1.5 SUMMARY OF CHANGES 48 2 RESEARCH METHODOLOGY 50 2.1 RESEARCH DATA 50 2.1.1 SECONDARY DATA 51 2.1.1.1 Key sources of secondary data 51 2.1.1.2 Key data from secondary sources 52 2.1.2 PRIMARY DATA 52 2.1.2.1 Key sources of primary data 53 2.1.2.2 Key objectives of primary research 53 2.1.2.3 Key data from primary sources 54 2.1.2.4 Insights from primary experts 55 2.2 RESEARCH APPROACH 56 2.3 MARKET SIZE ESTIMATION 56 2.3.1 REVENUE SHARE ANALYSIS (SUPPLY-SIDE ANALYSIS) 57 2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION) 58 2.3.3 TOP-DOWN APPROACH 59 2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 60 2.4 DATA TRIANGULATION 63 2.5 MARKET SHARE ESTIMATION 64 2.6 STUDY ASSUMPTIONS 64 2.7 RESEARCH LIMITATIONS 64 2.7.1 METHODOLOGY-RELATED LIMITATIONS 64 2.7.2 SCOPE-RELATED LIMITATIONS 65 2.8 RISK ASSESSMENT 65 3 EXECUTIVE SUMMARY 66 4 PREMIUM INSIGHTS 72 4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 72 4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER AND REGION 73 4.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT 74 4.4 TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS 75 5 MARKET OVERVIEW 76 5.1 INTRODUCTION 76 5.2 MARKET DYNAMICS 76 5.2.1 DRIVERS 78 5.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure 78 5.2.1.2 Rising prevalence of chronic diseases 80 5.2.1.3 Reduced time and lower out-of-pocket costs 81 5.2.1.4 Advancements in telecommunication technologies 81 5.2.1.5 Shortage of skilled healthcare professionals 81 5.2.1.6 Increased government support and favorable regulatory policies 82 5.2.1.7 Expansion of remote patient monitoring systems 83 5.2.2 RESTRAINTS 84 5.2.2.1 High investment costs for B2B models and lack of IT expertise 84 5.2.2.2 State-to-state and inter-country regulatory variations 85 5.2.2.3 Behavioral reluctance to adopt new technologies 86 5.2.2.4 Rise in fraud and abuse in healthcare systems 86 5.2.2.5 Adherence to patient privacy, confidentiality, medical ethics 87 5.2.3 OPPORTUNITIES 87 5.2.3.1 Growing use of wearables, applications, and sensors for virtual care 87 5.2.3.2 Emergence of AI and ML 88 5.2.3.3 Increasing shift toward outpatient care models 88 5.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics 89 5.2.3.5 Expansion of hospital-at-home (HaH) initiatives 90 5.2.3.6 Demand for electronic medical record-based telehealth services 90 5.2.3.7 Rising incidence of mental illnesses and growing focus on emotional well-being 90 5.2.4 CHALLENGES 91 5.2.4.1 Data security and confidentiality concerns 91 5.2.4.2 Limited data accessibility 95 5.2.4.3 Inability to maintain patient hygiene and cleanliness standards 95 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 95 5.4 INDUSTRY TRENDS 96 5.5 ECOSYSTEM ANALYSIS 100 5.6 VALUE CHAIN ANALYSIS 103 5.7 TECHNOLOGY ANALYSIS 105 5.7.1 KEY TECHNOLOGIES 105 5.7.1.1 Video conferencing and real-time communication platforms 105 5.7.1.2 AI and ML 105 5.7.1.3 Virtual assistants and chatbots 105 5.7.1.4 Voice recognition and natural language processing 106 5.7.1.5 EHR integration 106 5.7.1.6 Remote patient monitoring systems 106 5.7.2 COMPLEMENTARY TECHNOLOGIES 106 5.7.2.1 Edge computing 106 5.7.2.2 Cloud computing 107 5.7.2.3 Mobile health (mHealth) applications 107 5.7.2.4 Wearable devices, sensors, and IoT 107 5.7.3 ADJACENT TECHNOLOGIES 108 5.7.3.1 Digital therapeutics 108 5.7.3.2 Blockchain technology 108 5.7.3.3 Augmented reality and virtual reality 108 5.8 TARIFF AND REGULATORY ANALYSIS 109 5.8.1 TARIFF DATA ANALYSIS 109 5.8.1.1 Tariff data for HS code 9018 109 5.8.1.2 Tariff data for HS code 9021 110 5.8.1.3 Tariff data for HS code 9022 111 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 5.8.3 REGULATORY STANDARDS 114 5.8.4 REGULATORY FRAMEWORK 114 5.9 TRADE ANALYSIS 117 5.9.1 TRADE DATA FOR HSN CODE 90189099 117 5.9.1.1 Top 10 importers for HSN code 90189099 117 5.9.1.2 Top 10 exporters for HSN code 90189099 118 5.9.2 TRADE DATA FOR HSN CODE 9021 118 5.9.2.1 Top 10 importers for HSN code 9021 118 5.9.2.2 Top 10 exporters for HSN code 9021 119 5.9.3 TRADE DATA FOR HSN CODE 9022 119 5.9.3.1 Top 10 importers for HSN code 9022 119 5.9.3.2 Top 10 exporters for HSN code 9022 120 5.10 PRICING ANALYSIS 120 5.10.1 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS, BY COMPONENT, 2023 121 5.10.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2023 122 5.10.3 PRICING MODELS 123 5.11 PORTER’S FIVE FORCES ANALYSIS 123 5.11.1 THREAT OF NEW ENTRANTS 125 5.11.2 THREAT OF SUBSTITUTES 125 5.11.3 BARGAINING POWER OF BUYERS 125 5.11.4 BARGAINING POWER OF SUPPLIERS 125 5.11.5 INTENSITY OF COMPETITIVE RIVALRY 126 5.12 KEY STAKEHOLDERS & BUYING CRITERIA 126 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 126 5.12.2 KEY BUYING CRITERIA 127 5.13 PATENT ANALYSIS 128 5.13.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE 128 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 129 5.14 UNMET NEEDS & END-USER EXPECTATIONS 130 5.14.1 UNMET NEEDS 130 5.14.2 END-USER EXPECTATIONS 131 5.15 KEY CONFERENCES & EVENTS, 2025–2026 132 5.16 CASE STUDY ANALYSIS 134 5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS 134 5.16.2 USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES 134 5.16.3 CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS 135 5.17 INVESTMENT & FUNDING SCENARIO 136 5.18 BUSINESS MODEL ANALYSIS 136 5.18.1 DIRECT-TO-PATIENT (D2P) MODEL 136 5.18.2 BUSINESS-TO-BUSINESS (B2B) MODEL 136 5.18.3 EMPLOYER-SPONSORED MODEL 137 5.18.4 SUBSCRIPTION-BASED MODEL 137 5.18.5 HYBRID TELEMEDICINE MODEL 137 5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODEL 137 5.18.7 VALUE-BASED CARE MODEL 138 5.19 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET 138 5.19.1 KEY USE CASES 139 5.19.2 MAJOR CASE STUDIES 140 5.19.2.1 AI to redefine treatment effectiveness and safety 140 5.19.2.2 AI-driven chatbots and telehealth to enhance mental health and chronic disease management 141 5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 142 5.19.3.1 Healthcare IT and EHR systems 142 5.19.3.2 Pharmaceuticals & drug discovery 142 5.19.3.3 Mental health tech 143 5.19.3.4 Healthcare analytics and insights 143 5.19.4 USER READINESS & IMPACT ASSESSMENT 143 5.19.4.1 User readiness 143 5.19.4.1.1 User A: Hospitals 143 5.19.4.1.2 User B: Ambulatory surgery centers 143 5.19.4.2 Impact assessment 143 5.19.4.2.1 User A: Hospitals 144 5.19.4.2.2 User B: Ambulatory surgery centers 144 5.20 REIMBURSEMENT SCENARIO ANALYSIS 144 6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 147 6.1 INTRODUCTION 148 6.2 HARDWARE 148 6.2.1 TELEHEALTH KITS, CARTS, AND STATIONS 149 6.2.1.1 Increased focus on streamlined workflows and quality of remote healthcare services to drive adoption 149 6.2.2 PATIENT MONITORING DEVICES 150 6.2.2.1 Cardiac monitoring devices 152 6.2.2.1.1 Cardiac monitoring telehealth devices to minimize need for frequent hospital visits and improve patient outcomes 152 6.2.2.2 Neurological monitoring devices 153 6.2.2.2.1 Focus on better neuro care with advanced telemedicine solutions to augment segment growth 153 6.2.2.3 Respiratory monitoring devices 154 6.2.2.3.1 Rising prevalence of respiratory diseases and demand for home-based healthcare to drive segment 154 6.2.2.4 Blood glucose monitoring devices 155 6.2.2.4.1 Increasing number of diabetic patients in low- and middle-income countries to augment need for remote monitoring 155 6.2.2.5 Fetal & neonatal monitoring devices 156 6.2.2.5.1 Focus on continuous and personalized care without frequent in-person visits to drive segment 156 6.2.2.6 Weight monitoring devices 157 6.2.2.6.1 Rising prevalence of obesity and increasing awareness about weight management to drive market 157 6.2.2.7 Multiparameter monitoring devices 158 6.2.2.7.1 Rise of home healthcare and increased demand for remote patient monitoring to propel segment growth 158 6.2.2.8 Pulse oximeter devices 158 6.2.2.8.1 Remote pulse oximeter devices to manage chronic respiratory conditions and help faster patient recovery 158 6.2.2.9 Other patient monitoring devices 159 6.3 SOFTWARE 160 6.3.1 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY 160 6.3.1.1 EHR-centric software 161 6.3.1.1.1 EHR-centric software to improve patient information accessibility and secure sharing across platforms 161 6.3.1.2 Non-EHR-centric software 162 6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate telehealth services without constraints 162 6.3.2 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE 162 6.3.2.1 Integrated software 163 6.3.2.1.1 Integrated software to streamline clinical workflow and promote better access to patient health data 163 6.3.2.2 Standalone software 164 6.3.2.2.1 Increased focus on flexibility and ease of usage to fuel adoption 164 6.3.3 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE 164 6.3.3.1 Remote patient monitoring platforms 165 6.3.3.1.1 Increased popularity of at-home chronic disease management among geriatric patients to aid market growth 165 6.3.3.2 Virtual care platforms 167 6.3.3.2.1 Real-time interaction platforms 167 6.3.3.2.1.1 Synchronous nature and better healthcare access to drive segment 167 6.3.3.2.2 Store & forward platforms 168 6.3.3.2.2.1 Easy monitoring of vital signs for long-term chronic care without physical presence to fuel segment growth 168 6.3.3.3 Video conferencing platforms 169 6.3.3.3.1 Need for collaborative and coordinated care for chronic patients to augment segment growth 169 6.3.3.4 Virtual sitting & nursing platforms 170 6.3.3.4.1 Reduced workload of on-site staff and prevention of costly hospital readmissions to boost segment growth 170 6.3.4 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT 171 6.3.4.1 On-premise deployment models 171 6.3.4.1.1 Enhanced control and safety of inventory data with better reuse of existing infrastructure to drive market 171 6.3.4.2 Cloud-based deployment models 172 6.3.4.2.1 Need to integrate information from disparate locations in real time for database registry to drive segment 172 6.4 SERVICES 173 6.4.1 COST-EFFECTIVENESS AND REDUCED STRAIN ON HEALTHCARE PROVIDERS TO DRIVE MARKET 173 7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION 175 7.1 INTRODUCTION 176 7.2 CLINICAL CARE MANAGEMENT 176 7.2.1 FOCUS ON REAL-TIME CONSULTATIONS, PROACTIVE MONITORING, AND FOLLOW-UP STRATEGIES TO DRIVE MARKET 176 7.3 PREVENTIVE CARE MANAGEMENT 177 7.3.1 PREVENTIVE CARE AMONG RURAL PATIENTS TO REDUCE DELAYED DIAGNOSIS AND IMPROVE PATIENT ENGAGEMENT 177 7.4 DIAGNOSTICS & TREATMENT 178 7.4.1 DIAGNOSIS & TREATMENT TO SUPPORT PROACTIVE CARE MANAGEMENT AND DEVELOP PERSONAL HEALTHCARE PLANS 178 7.5 REMOTE PATIENT MONITORING/PATIENT MONITORING 179 7.5.1 REMOTE PATIENT MONITORING TO REVOLUTIONIZE PATIENT CARE BY IMPROVING ACCESSIBILITY, EFFICIENCY, AND HEALTH OUTCOMES 179 7.6 REHABILITATION & RECOVERY 180 7.6.1 ADOPTION OF TELEREHABILITATION TO OVERCOME REGIONAL BARRIERS AND SUPPORT PATIENTS WITH MOBILITY CHALLENGES 180 7.7 ADMINISTRATIVE 181 7.7.1 EFFICIENT ADMINISTRATIVE TASKS TO ENHANCE WORKFLOW AND IMPROVE OPERATIONAL EFFICIENCY 181 7.8 ANALYTICS & REPORTING 182 7.8.1 ADVANCED DATA ANALYTICS & REPORTING TO SUPPORT PROACTIVE DECISION-MAKING AND FOSTER BETTER CARE COORDINATION 182 7.9 PATIENT ENGAGEMENT 183 7.9.1 PROACTIVE PATIENT ENGAGEMENT TO PROMOTE ADHERENCE TO TREATMENT PLANS AND ENABLE TIMELY INTERVENTIONS 183 7.10 OTHER FUNCTIONS 184 8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 186 8.1 INTRODUCTION 187 8.2 PRIMARY CARE 187 8.2.1 TECHNOLOGICAL ADVANCEMENTS AND CONVENIENT ACCESS TO HEALTHCARE FACILITIES TO AID MARKET GROWTH 187 8.3 SPECIALTY CARE 188 8.3.1 TELERADIOLOGY 190 8.3.1.1 Rise of cloud-based imaging solutions and AI-driven radiology tools to boost segment growth 190 8.3.2 TELECARDIOLOGY 191 8.3.2.1 Integration of AI, cloud-based ECG monitoring, and wearable health devices to fuel segment growth 191 8.3.3 TELENEUROLOGY 192 8.3.3.1 High prevalence of neurological disorders and incorporation of AI into diagnostic tools to spur segment growth 192 8.3.4 DIABETES 193 8.3.4.1 Rise in consumer demand for more accessible and cost-effective healthcare services to augment market growth 193 8.3.5 RESPIRATORY DISORDERS 193 8.3.5.1 Increasing global prevalence of chronic respiratory conditions among older adults to fuel market growth 193 8.3.6 HYPERTENSION 194 8.3.6.1 Need for continuous monitoring and rise of remote care technologies to propel market growth 194 8.3.7 TELEDERMATOLOGY 195 8.3.7.1 High prevalence of skin cancer and dermatology-related diseases to augment segment growth 195 8.3.8 TELESTROKE 196 8.3.8.1 Rising incidence of stroke and increasing geriatric population to drive market 196 8.3.9 TELEPSYCHIATRY 197 8.3.9.1 Shortage of mental health practitioners and poor access to psychiatric care in rural areas to fuel market growth 197 8.3.10 OTHER SPECIALTY CARE APPLICATIONS 198 8.4 TELEICU 199 8.4.1 INCREASED EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF SPECIALISTS TO SUPPORT MARKET GROWTH 199 8.5 VIRTUAL SITTING & NURSING 200 8.5.1 INCREASING DEMAND FOR HOME-BASED HEALTHCARE SERVICES TO FUEL MARKET GROWTH 200 8.6 OTHER APPLICATIONS 201 9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP 202 9.1 INTRODUCTION 203 9.2 PEDIATRICS 203 9.2.1 INCREASING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE FOR CHILDREN IN RURAL AREAS TO DRIVE MARKET 203 9.3 ADULTS 204 9.3.1 HIGH DEMAND FOR REMOTE ROUTINE CHECK-UPS AND CHRONIC DISEASE MANAGEMENT TO PROPEL MARKET GROWTH 204 9.4 GERIATRICS 205 9.4.1 RISING GERIATRIC POPULATION TO AUGMENT NEED FOR REMOTE MEDICAL CONSULTATIONS 205 10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER 207 10.1 INTRODUCTION 208 10.2 HEALTHCARE PROVIDERS 208 10.2.1 HOSPITALS 210 10.2.1.1 Increasing demand for advanced and high-quality to drive market 210 10.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 211 10.2.2.1 High preference, minimized patient downtime, and reduced hospital stay to augment segment growth 211 10.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 212 10.2.3.1 Need for prolonged treatment for chronic diseases and preference for participatory and preventive care to drive segment 212 10.2.4 HOME HEALTHCARE 213 10.2.4.1 Rising prevalence of chronic diseases and need for cost-effective solutions to aid market growth 213 10.2.5 OTHER HEALTHCARE PROVIDERS 214 10.3 HEALTHCARE PAYERS 214 10.3.1 PUBLIC HEALTHCARE PAYERS 216 10.3.1.1 Increasing healthcare R&D investments and favorable policies to drive segment 216 10.3.2 PRIVATE HEALTHCARE PAYERS 217 10.3.2.1 Implementation of telehealth services for mental health issues and substance usage to drive segment 217 10.4 PATIENTS 217 10.4.1 RISING GERIATRIC POPULATION TO INCREASE FOCUS ON TELEHEALTH SERVICES FOR LONG-TERM CARE NEEDS 217 10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 218 10.5.1 RISE OF VIRTUAL CONSULTATIONS AND TELEMEDICINE PLATFORMS TO INCREASE CLINICAL TRIALS WITHOUT REGIONAL BARRIERS 218 10.6 MEDTECH COMPANIES 219 10.6.1 INCREASED DEMAND FOR INNOVATIVE HEALTHCARE DEVICES FOR REMOTE DIAGNOSIS AND TREATMENT TO AID MARKET GROWTH 219 10.7 OTHER END USERS 220 11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION 222 11.1 INTRODUCTION 223 11.2 NORTH AMERICA 223 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 223 11.2.2 US 231 11.2.2.1 US to dominate North American telehealth & telemedicine market during study period 231 11.2.3 CANADA 238 11.2.3.1 Push for digital health integration to drive higher adoption of telehealth services 238 11.3 EUROPE 244 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 251 11.3.2 GERMANY 252 11.3.2.1 Favorable government legislation for digitalized healthcare to spur market growth 252 11.3.3 UK 258 11.3.3.1 Increased government focus on digital health solutions to aid market growth 258 11.3.4 FRANCE 265 11.3.4.1 Strategic investments and government policy reforms to fuel uptake of digital medical devices for treatment 265 11.3.5 ITALY 272 11.3.5.1 Increased government healthcare investments to foster greater efficiency and accessibility in digital health solutions 272 11.3.6 SPAIN 279 11.3.6.1 Developed eHealth sector and increased adoption of wearable health tracking devices to augment market growth 279 11.3.7 REST OF EUROPE 285 11.4 ASIA PACIFIC 292 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 300 11.4.2 CHINA 300 11.4.2.1 Investments in digital healthcare solutions to drive market 300 11.4.3 JAPAN 307 11.4.3.1 Favorable legal revisions and advancements in video and audio communication to aid market growth 307 11.4.4 INDIA 314 11.4.4.1 Ongoing digital transformation initiatives through favorable government schemes to support market adoption 314 11.4.5 AUSTRALIA 321 11.4.5.1 Significant government investments in rural, remote, and specialist aged care services to fuel uptake 321 11.4.6 REST OF ASIA PACIFIC 328 11.5 LATIN AMERICA 334 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 335 11.5.2 BRAZIL 342 11.5.2.1 Increased availability of smartphones and improved internet connectivity to propel market growth 342 11.5.3 MEXICO 349 11.5.3.1 Regulatory improvements in telemedicine consultations to boost market growth 349 11.5.4 REST OF LATIN AMERICA 356 11.6 MIDDLE EAST & AFRICA 363 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 363 11.6.2 GCC COUNTRIES 370 11.6.2.1 Shortage of healthcare workforce to drive adoption of telehealth services 370 11.6.3 REST OF MIDDLE EAST & AFRICA 377 12 COMPETITIVE LANDSCAPE 384 12.1 INTRODUCTION 384 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 384 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET 385 12.3 REVENUE ANALYSIS, 2019–2023 387 12.4 MARKET SHARE ANALYSIS, 2023 389 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 392 12.5.1 STARS 392 12.5.2 EMERGING LEADERS 392 12.5.3 PERVASIVE PLAYERS 392 12.5.4 PARTICIPANTS 392 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 394 12.5.5.1 Company footprint 394 12.5.5.2 Region footprint 395 12.5.5.3 Function footprint 396 12.5.5.4 Application footprint 397 12.5.5.5 Component footprint 398 12.5.5.6 End-user footprint 399 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 400 12.6.1 PROGRESSIVE COMPANIES 400 12.6.2 RESPONSIVE COMPANIES 400 12.6.3 DYNAMIC COMPANIES 400 12.6.4 STARTING BLOCKS 400 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 402 12.6.5.1 Detailed list of key startups/SMEs 402 12.6.5.2 Competitive benchmarking of key startups/SMEs 402 12.7 COMPANY VALUATION & FINANCIAL METRICS 403 12.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS 404 12.9 COMPETITIVE SCENARIO 405 12.9.1 PRODUCT LAUNCHES & APPROVALS 405 12.9.2 DEALS 406 12.9.3 EXPANSIONS 407 12.9.4 OTHER DEVELOPMENTS 407 13 COMPANY PROFILES 409 13.1 KEY PLAYERS 409 13.1.1 MEDTRONIC 409 13.1.1.1 Business overview 409 13.1.1.2 Products/Services/Solutions offered 410 13.1.1.3 Recent developments 412 13.1.1.3.1 Product launches & approvals 412 13.1.1.3.2 Deals 413 13.1.1.4 MnM view 414 13.1.1.4.1 Right to win 414 13.1.1.4.2 Strategic choices 414 13.1.1.4.3 Weaknesses & competitive threats 414 13.1.2 TELADOC HEALTH, INC. 415 13.1.2.1 Business overview 415 13.1.2.2 Products/Services/Solutions offered 416 13.1.2.3 Recent developments 417 13.1.2.3.1 Product launches & enhancements 417 13.1.2.3.2 Deals 418 13.1.2.4 MnM view 419 13.1.2.4.1 Right to win 419 13.1.2.4.2 Strategic choices 419 13.1.2.4.3 Weaknesses & competitive threats 419 13.1.3 CISCO SYSTEMS, INC. 420 13.1.3.1 Business overview 420 13.1.3.2 Products/Services/Solutions offered 421 13.1.3.3 MnM view 423 13.1.3.3.1 Right to win 423 13.1.3.3.2 Strategic choices 423 13.1.3.3.3 Weaknesses & competitive threats 423 13.1.4 KONINKLIJKE PHILIPS N.V. 424 13.1.4.1 Business overview 424 13.1.4.2 Products/Services/Solutions offered 425 13.1.4.3 Recent developments 428 13.1.4.3.1 Product launches & approvals 428 13.1.4.3.2 Deals 429 13.1.4.4 MnM view 431 13.1.4.4.1 Right to win 431 13.1.4.4.2 Strategic choices 431 13.1.4.4.3 Weaknesses & competitive threats 431 13.1.5 ZOOM COMMUNICATIONS, INC. 432 13.1.5.1 Business overview 432 13.1.5.2 Products/Services/Solutions offered 433 13.1.5.3 Recent developments 433 13.1.5.3.1 Deals 433 13.1.5.4 MnM view 434 13.1.5.4.1 Right to win 434 13.1.5.4.2 Strategic choices 434 13.1.5.4.3 Weaknesses & competitive threats 434 13.1.6 GE HEALTHCARE 435 13.1.6.1 Business overview 435 13.1.6.2 Products/Services/Solutions offered 436 13.1.6.3 Recent developments 438 13.1.6.3.1 Product launches & approvals 438 13.1.6.3.2 Deals 438 13.1.7 EPIC SYSTEMS CORPORATION 440 13.1.7.1 Business overview 440 13.1.7.2 Products/Services/Solutions offered 440 13.1.7.3 Recent developments 442 13.1.7.3.1 Product launches & enhancements 442 13.1.7.3.2 Deals 443 13.1.8 ORACLE 444 13.1.8.1 Business overview 444 13.1.8.2 Products/Services/Solutions offered 445 13.1.8.3 Recent developments 447 13.1.8.3.1 Product launches 447 13.1.8.3.2 Deals 447 13.1.9 DOXIMITY, INC. 450 13.1.9.1 Business overview 450 13.1.9.2 Products/Services/Solutions offered 451 13.1.9.3 Recent developments 452 13.1.9.3.1 Product enhancements 452 13.1.9.3.2 Deals 452 13.1.9.3.3 Other developments 453 13.1.10 AMERICAN WELL 454 13.1.10.1 Business overview 454 13.1.10.2 Products/Services/Solutions offered 455 13.1.10.3 Recent developments 456 13.1.10.3.1 Product launches 456 13.1.10.3.2 Deals 457 13.1.10.3.3 Other developments 457 13.1.11 SIEMENS HEALTHINEERS AG 458 13.1.11.1 Business overview 458 13.1.11.2 Products/Services/Solutions offered 459 13.1.11.3 Recent developments 461 13.1.11.3.1 Product launches & approvals 461 13.1.11.3.2 Deals 461 13.1.12 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.) 463 13.1.12.1 Business overview 463 13.1.12.2 Products/Services/Solutions offered 463 13.1.12.3 Recent developments 464 13.1.12.3.1 Deals 464 13.1.12.3.2 Other developments 465 13.1.13 AMC HEALTH 466 13.1.13.1 Business overview 466 13.1.13.2 Products/Services/Solutions offered 466 13.1.13.3 Recent developments 467 13.1.13.3.1 Deals 467 13.1.14 TELESPECIALISTS 468 13.1.14.1 Business overview 468 13.1.14.2 Products/Services/Solutions offered 468 13.1.14.3 Recent developments 469 13.1.14.3.1 Product launches 469 13.1.14.3.2 Deals 469 13.1.14.3.3 Other developments 469 13.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.) 470 13.1.15.1 Business overview 470 13.1.15.2 Products/Services/Solutions offered 471 13.1.15.3 Recent developments 471 13.1.15.3.1 Product launches 471 13.1.15.3.2 Deals 472 13.1.15.3.3 Expansions 472 13.1.16 CAREGILITY 473 13.1.16.1 Business overview 473 13.1.16.2 Products/Services/Solutions offered 473 13.1.16.3 Recent developments 474 13.1.16.3.1 Product launches 474 13.1.16.3.2 Deals 474 13.1.16.3.3 Other developments 475 13.1.17 CVS HEALTH 476 13.1.17.1 Business overview 476 13.1.17.2 Products/Services/Solutions offered 477 13.1.17.3 Recent developments 478 13.1.17.3.1 Product launches 478 13.1.17.3.2 Deals 478 13.1.18 EVERNORTH HEALTH, INC. 479 13.1.18.1 Business overview 479 13.1.18.2 Products/Services/Solutions offered 481 13.1.18.3 Recent developments 482 13.1.18.3.1 Deals 482 13.1.19 ELATION 483 13.1.19.1 Business overview 483 13.1.19.2 Products/Services/Solutions offered 483 13.1.19.3 Recent developments 483 13.1.19.3.1 Deals 483 13.1.20 IRON BOW TECHNOLOGIES 484 13.1.20.1 Business overview 484 13.1.20.2 Products/Services/Solutions offered 484 13.2 OTHER PLAYERS 486 13.2.1 TIMEDOC, INC. 486 13.2.2 CEREBRAL INC. 487 13.2.3 KINDBODY 488 13.2.4 TRANSCARENT 489 13.2.5 CARESIMPLE INC. 490 14 APPENDIX 491 14.1 DISCUSSION GUIDE 491 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 497 14.3 CUSTOMIZATION OPTIONS 499 14.4 RELATED REPORTS 499 14.5 AUTHOR DETAILS 500

TABLE 1 TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS 45 TABLE 2 TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS 64 TABLE 3 TELEHEALTH & TELEMEDICINE MARKET: RISK ASSESSMENT 65 TABLE 4 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 77 TABLE 5 CHRONIC DISEASES AND RELATED COST BURDEN IN US 80 TABLE 6 RECENT DEVELOPMENTS IN REMOTE PATIENT MONITORING SYSTEMS, JANUARY 2023–JANUARY 2025 83 TABLE 7 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH 85 TABLE 8 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011−2024 93 TABLE 9 INDUSTRY TRENDS IN TELEHEALTH & TELEMEDICINE MARKET 96 TABLE 10 OVERVIEW OF TELEHEALTH USE CASES 99 TABLE 11 TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM 102 TABLE 12 AVERAGE TARIFF FOR HS CODE 9018, 2023 109 TABLE 13 AVERAGE TARIFF FOR HS CODE 9021, 2023 110 TABLE 14 AVERAGE TARIFF FOR HS CODE 9022, 2023 111 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 18 TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS 114 TABLE 19 REGULATORY REQUIREMENTS IN NORTH AMERICA 114 TABLE 20 REGULATORY REQUIREMENTS IN EUROPE 115 TABLE 21 REGULATORY REQUIREMENTS IN ASIA PACIFIC 115 TABLE 22 REGULATORY REQUIREMENTS IN LATIN AMERICA 116 TABLE 23 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 116 TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND) 117 TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019–2023 (USD THOUSAND) 118 TABLE 26 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 118 TABLE 27 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND) 119 TABLE 28 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND) 119 TABLE 29 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019–2023 (USD THOUSAND) 120 TABLE 30 COST RANGE INVOLVED IN TELEMEDICINE DEVICES (USD) 121 TABLE 31 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS, BY COMPONENT, 2023 122 TABLE 32 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS, 2023 122 TABLE 33 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2023 123 TABLE 34 TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES 124 TABLE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE 126 TABLE 36 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 127 TABLE 37 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR TELEHEALTH & TELEHEALTH 129 TABLE 38 UNMET NEEDS IN TELEHEALTH & TELEMEDICINE MARKET 131 TABLE 39 END-USER EXPECTATIONS IN TELEHEALTH & TELEMEDICINE MARKET 131 TABLE 40 TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 132 TABLE 41 CASE 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA’S INTEGRATED SOLUTIONS 134 TABLE 42 CASE 2: USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES 134 TABLE 43 CASE 3: CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS 135 TABLE 44 AI TO REDEFINE TREATMENT EFFECTIVENESS AND SAFETY 140 TABLE 45 AI-DRIVEN CHATBOTS AND TELEHEALTH TO ENHANCE MENTAL HEALTH AND CHRONIC DISEASE MANAGEMENT 141 TABLE 46 TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS 145 TABLE 47 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 148 TABLE 48 TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 149 TABLE 49 TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 149 TABLE 50 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR TELEHEALTH KITS, CARTS, AND STATIONS, BY REGION, 2022–2030 (USD MILLION) 150 TABLE 51 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 150 TABLE 52 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 151 TABLE 53 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (THOUSANDS UNITS) 151 TABLE 54 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 152 TABLE 55 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 153 TABLE 56 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 155 TABLE 57 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 156 TABLE 58 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 156 TABLE 59 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 157 TABLE 60 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 158 TABLE 61 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PULSE OXIMETER DEVICES, BY REGION, 2022–2030 (USD MILLION) 159 TABLE 62 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR OTHER PATIENT MONITORING DEVICES, BY REGION, 2022–2030 (USD MILLION) 159 TABLE 63 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 160 TABLE 64 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 161 TABLE 65 TELEHEALTH & TELEMEDICINE EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 161 TABLE 66 TELEHEALTH & TELEMEDICINE NON-EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 162 TABLE 67 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 163 TABLE 68 TELEHEALTH & TELEMEDICINE INTEGRATED SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 163 TABLE 69 TELEHEALTH & TELEMEDICINE STANDALONE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 164 TABLE 70 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 165 TABLE 71 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR REMOTE PATIENT MONITORING PLATFORMS, BY REGION, 2022–2030 (USD MILLION) 166 TABLE 72 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL CARE PLATFORMS, BY REGION, 2022–2030 (USD MILLION) 167 TABLE 73 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIDEO CONFERENCING PLATFORMS, BY REGION, 2022–2030 (USD MILLION) 169 TABLE 74 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL SITTING & NURSING PLATFORMS, BY REGION, 2022–2030 (USD MILLION) 170 TABLE 75 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 171 TABLE 76 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT MODELS, BY REGION, 2022–2030 (USD MILLION) 172 TABLE 77 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT MODELS, BY REGION, 2022–2030 (USD MILLION) 173 TABLE 78 TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 174 TABLE 79 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 176 TABLE 80 TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL CARE MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 177 TABLE 81 TELEHEALTH & TELEMEDICINE MARKET FOR PREVENTIVE CARE MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 178 TABLE 82 TELEHEALTH & TELEMEDICINE MARKET FOR DIAGNOSTICS & TREATMENT, BY REGION, 2022–2030 (USD MILLION) 179 TABLE 83 TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING/ PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION) 180 TABLE 84 TELEHEALTH & TELEMEDICINE MARKET FOR REHABILITATION & RECOVERY, BY REGION, 2022–2030 (USD MILLION) 181 TABLE 85 TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE, BY REGION, 2022–2030 (USD MILLION) 182 TABLE 86 TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING, BY REGION, 2022–2030 (USD MILLION) 183 TABLE 87 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2022–2030 (USD MILLION) 184 TABLE 88 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 185 TABLE 89 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 187 TABLE 90 TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE, BY REGION, 2022–2030 (USD MILLION) 188 TABLE 91 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 189 TABLE 92 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY REGION, 2022–2030 (USD MILLION) 189 TABLE 93 TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2022–2030 (USD MILLION) 190 TABLE 94 TELEHEALTH & TELEMEDICINE MARKET FOR TELECARDIOLOGY, BY REGION, 2022–2030 (USD MILLION) 191 TABLE 95 TELEHEALTH & TELEMEDICINE MARKET FOR TELENEUROLOGY, BY REGION, 2022–2030 (USD MILLION) 192 TABLE 96 TELEHEALTH & TELEMEDICINE MARKET FOR DIABETES, BY REGION, 2022–2030 (USD MILLION) 193 TABLE 97 TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2022–2030 (USD MILLION) 194 TABLE 98 TELEHEALTH & TELEMEDICINE MARKET FOR HYPERTENSION, BY REGION, 2022–2030 (USD MILLION) 195 TABLE 99 TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2022–2030 (USD MILLION) 196 TABLE 100 TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY REGION, 2022–2030 (USD MILLION) 197 TABLE 101 TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2022–2030 (USD MILLION) 198 TABLE 102 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER SPECIALTY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 199 TABLE 103 TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2022–2030 (USD MILLION) 200 TABLE 104 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING, BY REGION, 2022–2030 (USD MILLION) 201 TABLE 105 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 201 TABLE 106 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 203 TABLE 107 TELEHEALTH & TELEMEDICINE MARKET FOR PEDIATRICS, BY REGION, 2022–2030 (USD MILLION) 204 TABLE 108 TELEHEALTH & TELEMEDICINE MARKET FOR ADULTS, BY REGION, 2022–2030 (USD MILLION) 205 TABLE 109 TELEHEALTH & TELEMEDICINE MARKET FOR GERIATRICS, BY REGION, 2022–2030 (USD MILLION) 206 TABLE 110 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 208 TABLE 111 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 209 TABLE 112 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 210 TABLE 113 TELEHEALTH & TELEMEDICINE MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION) 211 TABLE 114 TELEHEALTH & TELEMEDICINE MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION) 212 TABLE 115 TELEHEALTH & TELEMEDICINE MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION) 213 TABLE 116 TELEHEALTH & TELEMEDICINE MARKET FOR HOME HEALTHCARE, BY REGION, 2022–2030 (USD MILLION) 213 TABLE 117 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION) 214 TABLE 118 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 215 TABLE 119 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION) 215 TABLE 120 TELEHEALTH & TELEMEDICINE MARKET FOR PUBLIC HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION) 216 TABLE 121 TELEHEALTH & TELEMEDICINE MARKET FOR PRIVATE HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION) 217 TABLE 122 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION) 218 TABLE 123 TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION) 219 TABLE 124 TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION) 220 TABLE 125 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 221 TABLE 126 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION) 223 TABLE 127 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 224 TABLE 128 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 225 TABLE 129 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 225 TABLE 130 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 226 TABLE 131 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 226 TABLE 132 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 227 TABLE 133 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 227 TABLE 134 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 227 TABLE 135 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 228 TABLE 136 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 228 TABLE 137 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 229 TABLE 138 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 229 TABLE 139 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 230 TABLE 140 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 230 TABLE 141 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 231 TABLE 142 US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 232 TABLE 143 US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 232 TABLE 144 US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 233 TABLE 145 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 233 TABLE 146 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 234 TABLE 147 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 234 TABLE 148 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 234 TABLE 149 US: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 235 TABLE 150 US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 235 TABLE 151 US: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 236 TABLE 152 US: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 236 TABLE 153 US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 237 TABLE 154 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 237 TABLE 155 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 238 TABLE 156 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 238 TABLE 157 CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 239 TABLE 158 CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 239 TABLE 159 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 240 TABLE 160 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 240 TABLE 161 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 240 TABLE 162 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 241 TABLE 163 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 241 TABLE 164 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 242 TABLE 165 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 242 TABLE 166 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 243 TABLE 167 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 243 TABLE 168 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 244 TABLE 169 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 244 TABLE 170 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 245 TABLE 171 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 245 TABLE 172 EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 246 TABLE 173 EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 246 TABLE 174 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 247 TABLE 175 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 247 TABLE 176 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 247 TABLE 177 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 248 TABLE 178 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 248 TABLE 179 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 249 TABLE 180 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 249 TABLE 181 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 250 TABLE 182 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 250 TABLE 183 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 251 TABLE 184 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 251 TABLE 185 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 252 TABLE 186 GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 253 TABLE 187 GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 253 TABLE 188 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 254 TABLE 189 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 254 TABLE 190 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 254 TABLE 191 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 255 TABLE 192 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 255 TABLE 193 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 256 TABLE 194 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 256 TABLE 195 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 257 TABLE 196 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 257 TABLE 197 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 258 TABLE 198 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 258 TABLE 199 UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 259 TABLE 200 UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 259 TABLE 201 UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 260 TABLE 202 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 260 TABLE 203 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 261 TABLE 204 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 261 TABLE 205 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 261 TABLE 206 UK: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 262 TABLE 207 UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 262 TABLE 208 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 263 TABLE 209 UK: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 263 TABLE 210 UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 264 TABLE 211 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 264 TABLE 212 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 265 TABLE 213 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 266 TABLE 214 FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 266 TABLE 215 FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 267 TABLE 216 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 267 TABLE 217 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 268 TABLE 218 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 268 TABLE 219 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 268 TABLE 220 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 269 TABLE 221 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 269 TABLE 222 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 270 TABLE 223 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 270 TABLE 224 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 271 TABLE 225 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 271 TABLE 226 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 272 TABLE 227 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 273 TABLE 228 ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 273 TABLE 229 ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 274 TABLE 230 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 274 TABLE 231 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 275 TABLE 232 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 275 TABLE 233 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 275 TABLE 234 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 276 TABLE 235 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 276 TABLE 236 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 277 TABLE 237 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 277 TABLE 238 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 278 TABLE 239 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 278 TABLE 240 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 279 TABLE 241 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 279 TABLE 242 SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 280 TABLE 243 SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 280 TABLE 244 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 281 TABLE 245 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 281 TABLE 246 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 281 TABLE 247 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 282 TABLE 248 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 282 TABLE 249 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 283 TABLE 250 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 283 TABLE 251 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 284 TABLE 252 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 284 TABLE 253 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 285 TABLE 254 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 285 TABLE 255 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 286 TABLE 256 REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 286 TABLE 257 REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 287 TABLE 258 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 287 TABLE 259 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 288 TABLE 260 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 288 TABLE 261 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 288 TABLE 262 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 289 TABLE 263 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 289 TABLE 264 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 290 TABLE 265 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 290 TABLE 266 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 291 TABLE 267 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 291 TABLE 268 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 292 TABLE 269 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 294 TABLE 270 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 294 TABLE 271 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 294 TABLE 272 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 295 TABLE 273 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 295 TABLE 274 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 296 TABLE 275 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 296 TABLE 276 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 296 TABLE 277 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 297 TABLE 278 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 297 TABLE 279 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 298 TABLE 280 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 298 TABLE 281 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 299 TABLE 282 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 299 TABLE 283 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 300 TABLE 284 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 301 TABLE 285 CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 301 TABLE 286 CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 302 TABLE 287 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 302 TABLE 288 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 303 TABLE 289 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 303 TABLE 290 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 303 TABLE 291 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 304 TABLE 292 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 304 TABLE 293 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 305 TABLE 294 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 305 TABLE 295 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 306 TABLE 296 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 306 TABLE 297 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 307 TABLE 298 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 308 TABLE 299 JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 308 TABLE 300 JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 309 TABLE 301 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 309 TABLE 302 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 310 TABLE 303 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 310 TABLE 304 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 310 TABLE 305 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 311 TABLE 306 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 311 TABLE 307 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 312 TABLE 308 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 312 TABLE 309 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 313 TABLE 310 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 313 TABLE 311 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 314 TABLE 312 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 315 TABLE 313 INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 315 TABLE 314 INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 316 TABLE 315 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 316 TABLE 316 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 317 TABLE 317 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 317 TABLE 318 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 317 TABLE 319 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 318 TABLE 320 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 318 TABLE 321 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 319 TABLE 322 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 319 TABLE 323 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 320 TABLE 324 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 320 TABLE 325 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 321 TABLE 326 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 322 TABLE 327 AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 322 TABLE 328 AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 323 TABLE 329 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 323 TABLE 330 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 324 TABLE 331 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 324 TABLE 332 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 324 TABLE 333 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 325 TABLE 334 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 325 TABLE 335 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 326 TABLE 336 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 326 TABLE 337 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 327 TABLE 338 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 327 TABLE 339 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 328 TABLE 340 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 328 TABLE 341 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 329 TABLE 342 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 329 TABLE 343 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 330 TABLE 344 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 330 TABLE 345 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 330 TABLE 346 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 331 TABLE 347 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 331 TABLE 348 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 332 TABLE 349 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 332 TABLE 350 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 333 TABLE 351 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 333 TABLE 352 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 334 TABLE 353 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 334 TABLE 354 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 336 TABLE 355 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 336 TABLE 356 LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 336 TABLE 357 LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 337 TABLE 358 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 337 TABLE 359 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 338 TABLE 360 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 338 TABLE 361 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 338 TABLE 362 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 339 TABLE 363 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 339 TABLE 364 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 340 TABLE 365 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 340 TABLE 366 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 341 TABLE 367 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 341 TABLE 368 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 342 TABLE 369 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 343 TABLE 370 BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 343 TABLE 371 BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 344 TABLE 372 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 344 TABLE 373 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 345 TABLE 374 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 345 TABLE 375 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 345 TABLE 376 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 346 TABLE 377 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 346 TABLE 378 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 347 TABLE 379 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 347 TABLE 380 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 348 TABLE 381 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 348 TABLE 382 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 349 TABLE 383 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 350 TABLE 384 MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 350 TABLE 385 MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 351 TABLE 386 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 351 TABLE 387 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 352 TABLE 388 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 352 TABLE 389 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 352 TABLE 390 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 353 TABLE 391 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 353 TABLE 392 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 354 TABLE 393 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 354 TABLE 394 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 355 TABLE 395 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 355 TABLE 396 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 356 TABLE 397 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 357 TABLE 398 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 357 TABLE 399 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 358 TABLE 400 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 358 TABLE 401 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 359 TABLE 402 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 359 TABLE 403 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 359 TABLE 404 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 360 TABLE 405 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 360 TABLE 406 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 361 TABLE 407 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 361 TABLE 408 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 362 TABLE 409 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 362 TABLE 410 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 363 TABLE 411 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022–2030 (USD MILLION) 364 TABLE 412 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 364 TABLE 413 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 364 TABLE 414 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 365 TABLE 415 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 365 TABLE 416 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 366 TABLE 417 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 366 TABLE 418 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 366 TABLE 419 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 367 TABLE 420 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 367 TABLE 421 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 368 TABLE 422 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 368 TABLE 423 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 369 TABLE 424 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 369 TABLE 425 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 370 TABLE 426 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 370 TABLE 427 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 371 TABLE 428 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 371 TABLE 429 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 372 TABLE 430 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 372 TABLE 431 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 372 TABLE 432 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 373 TABLE 433 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 373 TABLE 434 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 374 TABLE 435 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 374 TABLE 436 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 375 TABLE 437 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 375 TABLE 438 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 376 TABLE 439 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 376 TABLE 440 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 377 TABLE 441 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 377 TABLE 442 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022–2030 (USD MILLION) 378 TABLE 443 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 378 TABLE 444 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 379 TABLE 445 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022–2030 (USD MILLION) 379 TABLE 446 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 379 TABLE 447 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 380 TABLE 448 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 380 TABLE 449 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022–2030 (USD MILLION) 381 TABLE 450 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022–2030 (USD MILLION) 381 TABLE 451 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 382 TABLE 452 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 382 TABLE 453 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION) 383 TABLE 454 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021–JANUARY 2025 385 TABLE 455 TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION 390 TABLE 456 TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT 395 TABLE 457 TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT 396 TABLE 458 TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT 397 TABLE 459 TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT 398 TABLE 460 TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT 399 TABLE 461 TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 402 TABLE 462 TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 402 TABLE 463 TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 405 TABLE 464 TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2021–JANUARY 2025 406 TABLE 465 TELEHEALTH & TELEMEDICINE MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 407 TABLE 466 TELEHEALTH & TELEMEDICINE MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 407 TABLE 467 MEDTRONIC: COMPANY OVERVIEW 409 TABLE 468 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 410 TABLE 469 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 412 TABLE 470 MEDTRONIC: DEALS, JANUARY 2021–JANUARY 2025 413 TABLE 471 TELADOC HEALTH, INC.: COMPANY OVERVIEW 415 TABLE 472 TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 416 TABLE 473 TELADOC HEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 417 TABLE 474 TELADOC HEALTH, INC.: DEALS, JANUARY 2021–JANUARY 2025 418 TABLE 475 CISCO SYSTEMS, INC.: COMPANY OVERVIEW 420 TABLE 476 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 421 TABLE 477 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 424 TABLE 478 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 425 TABLE 479 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 428 TABLE 480 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–JANUARY 2025 429 TABLE 481 ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW 432 TABLE 482 ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 433 TABLE 483 ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2021–JANUARY 2025 433 TABLE 484 GE HEALTHCARE: COMPANY OVERVIEW 435 TABLE 485 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 436 TABLE 486 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 438 TABLE 487 GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025 438 TABLE 488 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 440 TABLE 489 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 440 TABLE 490 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–JANUARY 2025 442 TABLE 491 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 443 TABLE 492 ORACLE: COMPANY OVERVIEW 444 TABLE 493 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 445 TABLE 494 ORACLE: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 447 TABLE 495 ORACLE: DEALS, JANUARY 2021–JANUARY 2025 447 TABLE 496 DOXIMITY, INC.: COMPANY OVERVIEW 450 TABLE 497 DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 451 TABLE 498 DOXIMITY, INC.: PRODUCT ENHANCEMENTS, JANUARY 2021–JANUARY 2025 452 TABLE 499 DOXIMITY, INC.: DEALS, JANUARY 2021–JANUARY 2025 452 TABLE 500 DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 453 TABLE 501 AMERICAN WELL: COMPANY OVERVIEW 454 TABLE 502 AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 455 TABLE 503 AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 456 TABLE 504 AMERICAN WELL: DEALS, JANUARY 2021–JANUARY 2025 457 TABLE 505 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 457 TABLE 506 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 458 TABLE 507 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 459 TABLE 508 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 461 TABLE 509 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–JANUARY 2025 461 TABLE 510 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): COMPANY OVERVIEW 463 TABLE 511 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED 463 TABLE 512 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): DEALS, JANUARY 2021–JANUARY 2025 464 TABLE 513 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 465 TABLE 514 AMC HEALTH: COMPANY OVERVIEW 466 TABLE 515 AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 466 TABLE 516 AMC HEALTH: DEALS, JANUARY 2021–JANUARY 2025 467 TABLE 517 TELESPECIALISTS: COMPANY OVERVIEW 468 TABLE 518 TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 468 TABLE 519 TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 469 TABLE 520 TELESPECIALISTS: DEALS, JANUARY 2021–JANUARY 2025 469 TABLE 521 TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 469 TABLE 522 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW 470 TABLE 523 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED 471 TABLE 524 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 471 TABLE 525 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): DEALS, JANUARY 2021- JANUARY 2025 472 TABLE 526 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): EXPANSIONS, JANUARY 2021–JANUARY 2025 472 TABLE 527 CAREGILITY: COMPANY OVERVIEW 473 TABLE 528 CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 473 TABLE 529 CAREGILITY: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 474 TABLE 530 CAREGILITY: DEALS, JANUARY 2021–JANUARY 2025 474 TABLE 531 CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 475 TABLE 532 CVS HEALTH: COMPANY OVERVIEW 476 TABLE 533 CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 477 TABLE 534 CVS HEALTH: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 478 TABLE 535 CVS HEALTH: DEALS, JANUARY 2021- JANUARY 2025 478 TABLE 536 EVERNORTH HEALTH, INC.: COMPANY OVERVIEW 479 TABLE 537 EVERNORTH HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 481 TABLE 538 EVERNORTH HEALTH, INC.: DEALS, JANUARY 2021–JANUARY 2025 482 TABLE 539 ELATION: COMPANY OVERVIEW 483 TABLE 540 ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 483 TABLE 541 ELATION: DEALS, JANUARY 2021–JANUARY 2025 483 TABLE 542 IRON BOW TECHNOLOGIES: COMPANY OVERVIEW 484 TABLE 543 IRON BOW TECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 484 TABLE 544 TIMEDOC, INC.: COMPANY OVERVIEW 486 TABLE 545 CEREBRAL INC.: COMPANY OVERVIEW 487 TABLE 546 KINDBODY: COMPANY OVERVIEW 488 TABLE 547 TRANSACARENT: COMPANY OVERVIEW 489 TABLE 548 CARESIMPLE INC.: COMPANY OVERVIEW 490 _ FIGURE 1 TELEHEALTH & TELEMEDICINE MARKET SEGMENTATION & GEOGRAPHICAL SPREAD 44 FIGURE 2 TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED 47 FIGURE 3 TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN 50 FIGURE 4 TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES 52 FIGURE 5 TELEHEALTH & TELEMEDICINE MARKET: KEY SOURCES OF PRIMARY DATA 53 FIGURE 6 TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES 54 FIGURE 7 TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES 55 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 55 FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 56 FIGURE 10 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 57 FIGURE 11 BOTTOM-UP APPROACH: END-USER SPENDING ON TELEHEALTH & TELEMEDICINE 59 FIGURE 12 TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH 60 FIGURE 13 TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 61 FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 62 FIGURE 15 TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION 63 FIGURE 16 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION) 66 FIGURE 17 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION) 67 FIGURE 18 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 68 FIGURE 19 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024 VS. 2030 (USD MILLION) 69 FIGURE 20 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 70 FIGURE 21 TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT 71 FIGURE 22 NEED TO IMPROVE ACCESSIBILITY AND REDUCE HEALTHCARE EXPENSES TO DRIVE MARKET 72 FIGURE 23 US AND HEALTHCARE PROVIDERS COMMANDED LARGEST MARKET SHARE IN 2023 73 FIGURE 24 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030 74 FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 75 FIGURE 26 TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 76 FIGURE 27 INCREASE IN POPULATION, 2022 VS. 2030 VS. 2050 (MILLION) 79 FIGURE 28 US: MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS, BY STATE (SEPTEMBER 2024) 89 FIGURE 29 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 92 FIGURE 30 US: MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024 92 FIGURE 31 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 93 FIGURE 32 TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 96 FIGURE 33 TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS 101 FIGURE 34 TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS 104 FIGURE 35 TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS 124 FIGURE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 126 FIGURE 37 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 127 FIGURE 38 GLOBAL PATENT PUBLICATION TRENDS IN TELEHEALTH & TELEMEDICINE, 2015–2024 128 FIGURE 39 JURISDICTION AND TOP APPLICANT ANALYSIS IN TELEHEALTH & TELEMEDICINE (2024) 129 FIGURE 40 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE (JANUARY 2015–DECEMBER 2024) 130 FIGURE 41 FUNDING AND NUMBER OF DEALS IN TELEHEALTH & TELEMEDICINE MARKET 136 FIGURE 42 POTENTIAL OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET 139 FIGURE 43 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 224 FIGURE 44 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 293 FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, 2019–2023 (USD MILLION) 388 FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET (2023) 389 FIGURE 47 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 393 FIGURE 48 TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT 394 FIGURE 49 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 401 FIGURE 50 EV/EBITDA OF KEY VENDORS, 2024 403 FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024 403 FIGURE 52 TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 404 FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT 410 FIGURE 54 TELADOC HEALTH, INC.: COMPANY SNAPSHOT 416 FIGURE 55 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT 421 FIGURE 56 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 425 FIGURE 57 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT 432 FIGURE 58 GE HEALTHCARE: COMPANY SNAPSHOT 436 FIGURE 59 ORACLE: COMPANY SNAPSHOT 445 FIGURE 60 DOXIMITY, INC.: COMPANY SNAPSHOT 451 FIGURE 61 AMERICAN WELL: COMPANY SNAPSHOT 454 FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 459 FIGURE 63 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT 470 FIGURE 64 CVS HEALTH: COMPANY SNAPSHOT 477 FIGURE 65 EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT 480

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（醫療與生命科學）